Cynosure's Accolade TM Workstation For Pigmented Lesions Receives Korean Regulatory Approval

Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, announced that it has received market approval from the Korea Food & Drug Administration (KFDA) for its flagship Accolade(TM) workstation for the removal of pigmented lesions.

Revolutionary Genetic Test For Women's Hair Loss Launched

HairDX, LLC (http://www.hairdx.com) pioneers of consumer-friendly genetic tests for hair loss, today introduced the first meaningful test using genetic markers strongly associated with Female Hair Loss (Female Androgenetic Alopecia). The easy to understand test provides an accurate and understandable genetic analysis of a woman's likelihood of developing this common type of hair loss.

Aeolus Pharmaceuticals' AEOL 10150 Provides Significant Protection Of Lungs And Skin In Animal Studies Of Mustard Gas Exposure

Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Research and Medical Center and the University of Colorado have completed a series of studies demonstrating that AEOL 10150 provides statistically significant protection of the lungs and skin in the 2-chloroethyl-ethylsulfide (CEES;

Delcath Expands Phase III Trial For Metastatic Melanoma To Include University Of Maryland Medical Center

Delcath Systems, Inc. (Nasdaq: DCTH) announced that the Institutional Review Board (IRB) of the University of Maryland Medical Center (UMMC) has approved UMMC's participation in the Phase III study of the Company's Percutaneous Hepatic Perfusion (PHP) System for the isolated, high dose delivery of the anti-cancer agent melphalan to treat inoperable metastatic melanoma in the liver.

Recent Advances Make Sunscreen More Effective And Easier To Use

With spring in the air, most of us will be arming ourselves with all the essentials that warm weather brings -- flip flops, shorts, sunglasses, sun hats and, of course, sunscreen. The available options in sunscreen protection have become more plentiful than ever, including formulations offering a smoother application or enhanced protection from ultraviolet (UV) light.

Scalp And Neck Melanoma Survival

"Skin cancers on the scalp or neck are more deadly than those elsewhere on the body, a large study has suggested", BBC News reported. The Daily Telegraph also describes the results of a new study that examined the prognosis (chance of survival) of patients who developed a malignant melanoma on their scalp or neck.

FDA Clears Glove Made From New Type Of Latex

The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.

Melanoma Lurks In Larger Skin Lesions

Skin lesions that are about the size of a pencil eraser are more likely to be melanomas, a deadly form of skin cancer, than smaller moles, according to a new study led by NYU Langone Medical Center researchers.In a new study published in the April issue of Archives of Dermatology, the NYU researchers confirm that an important warning sign of melanoma moles that are larger than 6 millimeters, the size of a pencil eraser is still valid.

Migraine Increases Risk Of Severe Skin Sensitivity And Pain

People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one's head, combing one's hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

Most Lethal Melanomas Are On Scalp And Neck

People with scalp or neck melanomas die at nearly twice the rate of people with melanoma elsewhere on the body, including the face or ears, researchers at the University of North Carolina at Chapel Hill have found.The analysis of 51, 704 melanoma cases in the U.